Clinical Rheumatology

, Volume 28, Issue 8, pp 975–978 | Cite as

Mean platelet volume in children with familial Mediterranean fever

  • Balahan MakayEmail author
  • Zeynep Türkyilmaz
  • Erbil Ünsal
Brief Report


Familial Mediterranean fever (FMF) is the most common inherited periodic fever syndrome characterized by recurrent episodes of serositis. Recently, a few studies have suggested that FMF is related to increased risk of atherosclerosis. Mean platelet volume (MPV) is a marker of platelet activation. Larger platelets are associated with increased atherosclerosis risk. The aim of the study is to evaluate levels of MPV in pediatric FMF patients during and between attacks. The study consisted of 48 patients during an attack (group 1), 63 patients in attack-free period (at least 2 weeks after an attack, group 2), and 49 healthy controls (group 3). Erythrocyte sedimentation rate, C-reactive protein, white blood cell count, platelet count (PLT), and MPV levels were retrospectively recorded from the computerized patient database. Mean platelet volume was significantly lower in FMF patients during attack than in attack-free period (p = 0.00); however, there was no difference among attack-free patients and healthy controls (p = 0.38). The mean platelet counts of FMF patients during attack were higher than the healthy controls (p = 0.02). There was an inverse correlation between MPV and mean PLT in the attack-free period (r = −446, p = 0.01). This study suggests that an early atherosclerosis marker, MPV, is not elevated in pediatric FMF patients on colchicine treatment.


Atherosclerosis Children Familial Mediterranean fever Mean platelet volume 





  1. 1.
    Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690Google Scholar
  2. 2.
    Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. New Eng J Med 291:932–934PubMedCrossRefGoogle Scholar
  3. 3.
    Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New Eng J Med 314:1001–1005Google Scholar
  4. 4.
    Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRefGoogle Scholar
  5. 5.
    Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191PubMedCrossRefGoogle Scholar
  6. 6.
    Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:161–167CrossRefGoogle Scholar
  7. 7.
    Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial Mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353PubMedCrossRefGoogle Scholar
  8. 8.
    Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689–694PubMedCrossRefGoogle Scholar
  9. 9.
    Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216PubMedCrossRefGoogle Scholar
  10. 10.
    Ross R (1986) The pathogenesis of atherosclerosis—an update. New Eng J Med 314:488–500PubMedGoogle Scholar
  11. 11.
    Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRefGoogle Scholar
  12. 12.
    Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRefGoogle Scholar
  13. 13.
    Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519PubMedCrossRefGoogle Scholar
  14. 14.
    Çoban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19:405–408PubMedCrossRefGoogle Scholar
  15. 15.
    Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRefGoogle Scholar
  16. 16.
    Pras E, Livneh A, Balow JE Jr et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219PubMedCrossRefGoogle Scholar
  17. 17.
    Seyahi E, Ugurlu S, Cumali R et al (2005) Subclinical atherosclerosis in familial Mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, 6–10 November 2005Google Scholar
  18. 18.
    Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725PubMedCrossRefGoogle Scholar
  19. 19.
    van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441PubMedGoogle Scholar
  20. 20.
    Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723PubMedCrossRefGoogle Scholar
  21. 21.
    Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101PubMedCrossRefGoogle Scholar
  22. 22.
    Gang N, Drenth JP, Langevitz P et al (1999) Activation of the cytokine network in familial Mediterranean fever. Rheumatol 26:890–897Google Scholar

Copyright information

© Clinical Rheumatology 2009

Authors and Affiliations

  • Balahan Makay
    • 1
    Email author
  • Zeynep Türkyilmaz
    • 1
  • Erbil Ünsal
    • 1
  1. 1.Department of Pediatrics, Division of Pediatric Immunology and RheumatologyDokuz Eylül University HospitalIzmirTurkey

Personalised recommendations